Litigation Details for BRISTOL-MYERS SQUIBB CO. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
✉ Email this page to a colleague
BRISTOL-MYERS SQUIBB CO. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-03-25 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-08-27 |
| Cause | 35:271 Patent Infringement | Assigned To | Michael Andre Shipp |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 7,491,725 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BRISTOL-MYERS SQUIBB CO. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for BRISTOL-MYERS SQUIBB CO. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-03-25 | 1 | Complaint | and legally issued United States Patent No. 7,491,725 (“the ’725 patent”) entitled “Process for preparing…prior to the expiration of United States Patent No. 7,491,725. …BACKGROUND U.S. PATENT NO. 7,491,725 On February 17, 2009, the…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United… correct copy of the ’725 patent is attached as Exhibit 1. The ’725 patent is assigned to BMS. | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
